Worst Pills
oxymorphone (OPANA, OPANA ER)

Worst Pills, Best Pills Newsletter Articles

Search results below include Worst Pills, Best Pills Newsletter Articles where your selected drug is a primary subject of discussion
  • Long-Acting Opioids: Extra Caution Needed [hide all summaries]
    (December 2015)
    In this article, we review new evidence suggesting that long-acting opioids are associated with a higher risk of unintentional life-threatening over¬doses than short-acting forms of these drugs.
  • FDA Should Change Labels On Opioid Painkillers to Deter Misprescribing [hide all summaries]
    (September 2012)
    The article reviews a recent petition to the FDA seeking improvements on the labels of prescription opioids (narcotics). The label change would prevent drug companies from promoting these drugs for noncancer pain for dangerously long periods of time, at doses that are too high, and for uses other than severe pain in noncancer patients. The petition was signed by 37 public health experts, including leaders in the fields of pain medicine, addiction and primary care; the health commissioners of New York City and New York state; and Dr. Sidney Wolfe, director of Public Citizen’s Health Research Group.

SHOW secondary search results for oxymorphone (OPANA, OPANA ER)

Copyright © 2017 Public Citizen's Health Research Group. All rights reserved. https://www.worstpills.org/